Works matching IS 1462-8902 AND VI 19 AND IP 1 AND DT 2017


Results: 18
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 78, doi. 10.1111/dom.12786
    By:
    • Josse, Robert G.;
    • Majumdar, Sumit R.;
    • Zheng, Yinggan;
    • Adler, Amanda;
    • Bethel, M. Angelyn;
    • Buse, John B.;
    • Green, Jennifer B.;
    • Kaufman, Keith D.;
    • Rodbard, Helena W.;
    • Tankova, Tsvetalina;
    • Westerhout, Cynthia M.;
    • Peterson, Eric D.;
    • Holman, Rury R.;
    • Armstrong, Paul W.
    Publication type:
    Article
    11

    Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial ( INICOM study).

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 87, doi. 10.1111/dom.12787
    By:
    • Lim, Soo;
    • Han, Kyung Ah;
    • Yu, JaeMyung;
    • Chamnan, Parinya;
    • Kim, Eun Sook;
    • Yoon, Kun‐Ho;
    • Kwon, Sam;
    • Moon, Min Kyong;
    • Lee, Kwan Woo;
    • Kim, Dong‐Jun;
    • Kim, Mikyung;
    • Wongtanate, Manaj;
    • Kim, Eun Young;
    • Kim, Sung‐Ho;
    • Lee, Moon‐Kyu
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18

    News and Views.

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 1, p. 148, doi. 10.1111/dom.12846
    By:
    • Idris, Iskandar
    Publication type:
    Article